Genetic polymorphism of CYP2D6 in a Keralite (South India) population

被引：0
作者：
Abraham, BK [1 ]
Adithan, C
Shashindran, CH
Vasu, S
Alekutty, NA
机构：
[1] Jawaharlal Inst Postgrad Med Educ & Res, Dept Pharmacol, Pondicherry 605006, India
[2] Mahatma Gandhi Univ, Dept Pharmaceut Sci, Kottayam, Kerala, India
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2000年 / 49卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：285 / 286
页数：2
相关论文
共 50 条
  • [21] Genetic polymorphism of CYP2D6 in North Indian subjects
    V. Lamba
    J. K. Lamba
    J. B. Dilawari
    K. K. Kohli
    [J]. European Journal of Clinical Pharmacology, 1998, 54 : 787 - 791
  • [22] Genetic polymorphism of CYP2D6 in North Indian subjects
    Lamba, V
    Lamba, JK
    Dilawari, JB
    Kohli, KK
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (9-10) : 787 - 791
  • [23] Effect of CYP2D6 genetic polymorphism on peak propafenone concentration: no significant effect of CYP2D6*10
    Doki, Kosuke
    Shirayama, Yuki
    Sekiguchi, Yukio
    Aonuma, Kazutaka
    Kohda, Yukinao
    Ieda, Masaki
    Homma, Masato
    [J]. PHARMACOGENOMICS, 2020, 21 (18) : 1279 - 1288
  • [24] Genetic polymorphism of CYP2D6: Malaysian Indians have the highest frequency for CYP2D6*4 in Asia
    Rusli Ismail
    L. Teh
    [J]. European Journal of Clinical Pharmacology, 2001, 57 : 617 - 618
  • [25] Genetic polymorphism of CYP2D6:: Malaysian Indians have the highest frequency for CYP2D6*4 in Asia
    Ismail, R
    Teh, LK
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 57 (08) : 617 - 618
  • [26] GENETIC-POLYMORPHISM OF CYTOCHROME-P450 CYP2D6 IN ZIMBABWEAN POPULATION
    MASIMIREMBWA, CM
    JOHANSSON, I
    HASLER, JA
    INGELMANSUNDBERG, M
    [J]. PHARMACOGENETICS, 1993, 3 (06): : 275 - 280
  • [27] Population pharmacokinetic analysis of tramadol and O-desmethyltramadol with genetic polymorphism of CYP2D6
    Lee, Joomi
    Yoo, Hee-Doo
    Bae, Jung-Woo
    Lee, Sooyeun
    Shin, Kwang-Hee
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 1751 - 1761
  • [28] Significance of genetic polymorphism of CYP2D6 in the pathogenesis of systemic sclerosis
    Baranska, Malgorzata
    Dziankowska-Bartkowiak, Bozena
    Waszczykowska, Elzbieta
    Rychlik-Sych, Mariola
    Skretkowicz, Jadwiga
    [J]. PHARMACOLOGICAL REPORTS, 2012, 64 (02) : 336 - 342
  • [29] The effect of CYP2D6 genetic polymorphism on baseline brain perfusion
    Stingl Kirchheiner J.C.
    Viviani R.
    [J]. Molecular Psychiatry, 2011, 16 (3) : 237 - 237
  • [30] The Impact of the CYP2D6 "Enhancer" Single Nucleotide Polymorphism on CYP2D6 Activity
    Dinh, Jean C.
    Boone, Erin C.
    Staggs, Vincent S.
    Pearce, Robin E.
    Wang, Wendy Y.
    Gaedigk, Roger
    Leeder, James Steven
    Gaedigk, Andrea
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (03) : 646 - 654
12345